Anika Therapeutics Inc — Liquidità (NASDAQ:ANIK) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative 13.06 M8.4 M4.41 M-1.79 M5.4 M11.19 M 11.19 M Flussi di cassa derivanti dalle attività di investimento -71.26 M-3.12 M-7.49 M-5.43 M-8.33 M-401 K -401 K Liquidità derivante dalle attività di finanziamento -3.77 M-6.78 M-4.85 M-6.32 M-12.73 M-10.55 M -10.55 M Liquidità libera 11.44 M3.25 M-3.08 M-7.21 M-2.93 M4.36 M 4.36 M

Notizie

Top 2 Health Care Stocks That May Crash This Quarter - Arcellx (NASDAQ:ACLX), Anika Therapeutics (NASDAQ:ANIK)

Anika Therapeutics, Inc. (ANIK) Presents at 2026 CG Musculoskeletal Conference - Slideshow (NASDAQ:ANIK) 2026-03-02

Anika alla Conferenza CG Musculoskeletal 2026: Focus sulla Crescita Strategica

Anika at 2026 CG Musculoskeletal Conference: Strategic Growth Focus

Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates

Anika Q4 2025: l’impennata commerciale compensa il calo OEM

Anika Q4 2025 slides: commercial surge offsets OEM decline

Anika earnings beat by $0.45, revenue topped estimates

Lumicell appoints Cheryl Blanchard to board of directors

Anika Therapeutics names Stephen Griffin as new CEO

Slide di Anika del Q3 2025: La crescita commerciale compensa il calo OEM

Anika Q3 2025 slides: Commercial growth offsets OEM decline